NervGen Pharma Corp. (NGEN) SEC filings
NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.96+0.14 (+7.69%)
Close on Nov 17, 2026Market cap $156.11MP/E –Yield –
SEC filings
15 of NervGen Pharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 6-K | Sep 25, 2026 | Sep 25, 2026 | SEC EDGAR |
| Current report | 6-K | Sep 24, 2026 | Sep 24, 2026 | SEC EDGAR |
| Current report | 6-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 6-K | Jul 2, 2026 | Jul 2, 2026 | SEC EDGAR |
| Current report | 6-K | Jun 1, 2026 | Jun 1, 2026 | SEC EDGAR |
| Current report | 6-K | May 26, 2026 | May 26, 2026 | SEC EDGAR |
| Current report | 6-K | May 22, 2026 | May 22, 2026 | SEC EDGAR |
| Current report | 6-K | May 18, 2026 | May 18, 2026 | SEC EDGAR |
| Current report | 6-K | May 15, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 6-K | Apr 27, 2026 | Apr 27, 2026 | SEC EDGAR |
| Annual report | 40-F | Dec 31, 2025 | Mar 31, 2026 | SEC EDGAR |
| Current report | 6-K | Mar 13, 2026 | Mar 13, 2026 | SEC EDGAR |
| Current report | 6-K | Feb 13, 2026 | Feb 13, 2026 | SEC EDGAR |
| Current report | 6-K | Feb 10, 2026 | Feb 10, 2026 | SEC EDGAR |
| Current report | 6-K | Jan 8, 2026 | Jan 8, 2026 | SEC EDGAR |
See a number that looks wrong?